Ogura Takeshi, Onda Saori, Takagi Wataru, Kitano Masayuki, Sano Tastsushi, Okuda Atsushi, Miyano Akira, Masuda Daisuke, Takeuchi Toshihisa, Fukunishi Shinya, Higuchi Kazuhide
2nd Department of Internal Medicine, Osaka Medical College, 2-7 Daigakuchou, Takatsukishi, Osaka 569-8686, Japan.
2nd Department of Internal Medicine, Osaka Medical College, Osaka, Japan.
Therap Adv Gastroenterol. 2016 Sep;9(5):722-8. doi: 10.1177/1756283X16651855. Epub 2016 Jun 7.
Temporary stent placement is widely performed for pancreatic duct stenosis due to chronic pancreatitis. A fully covered self-expandable metal stent (FCSEMS) has a larger diameter, and therefore longer stent patency, and the effect of expansion of the main pancreatic duct stricture may be obtained. However, if stent migration upstream occurs, stent removal is extremely difficult. In addition, because of the diameter gap between the FCSEMS and the main pancreatic duct, stent-induced ductal change may occur. To prevent these adverse events, the technical feasibility, safety and efficacy of the placement of a novel 6 mm diameter FCSEMS with a long suture, to facilitate its removal in cases of stent migration upstream, were evaluated in a pilot study.
Between December 2014 and August 2015, symptomatic chronic pancreatitis patients with abdominal pain and a main pancreatic head duct stricture were enrolled. Stent placement for main pancreatic duct stricture was performed under endoscopic retrograde cholangiopancreatography (ERCP) guidance and stent removal was performed within 6 months.
A total of 13 patients were retrospectively enrolled in this study. Metal stent insertion was successfully performed in all patients and clinical success was high (12/13, 92%). As adverse events, stent migration upstream was seen in two patients. Another 11 patients successfully underwent stent removal without any adverse events. During follow up (median 258 days), 2 patients still underwent pancreatic duct stenting because of continuing main pancreatic duct stricture.
In conclusion, this novel FCSEMS is acceptable for stent placement in cases of chronic pancreatitis with a main pancreatic duct stricture.
因慢性胰腺炎导致的胰管狭窄,常采用临时支架置入术。全覆膜自膨式金属支架(FCSEMS)直径更大,因此支架通畅时间更长,可能获得主胰管狭窄扩张的效果。然而,如果支架向上游迁移,取出支架极其困难。此外,由于FCSEMS与主胰管之间存在直径差异,可能会发生支架导致的导管改变。为预防这些不良事件,在一项前瞻性研究中评估了一种新型直径6mm且带有长缝线的FCSEMS置入术的技术可行性、安全性和有效性,以便在支架向上游迁移时便于取出。
2014年12月至2015年8月,纳入有腹痛症状且主胰头导管狭窄的慢性胰腺炎患者。在逆行胰胆管造影术(ERCP)引导下进行主胰管狭窄的支架置入,并在6个月内取出支架。
本研究共回顾性纳入13例患者。所有患者均成功置入金属支架,临床成功率较高(12/13,92%)。作为不良事件,2例患者出现支架向上游迁移。另外11例患者成功取出支架,无任何不良事件。在随访期间(中位时间258天),2例患者因主胰管持续狭窄仍需进行胰管支架置入。
总之,这种新型FCSEMS对于主胰管狭窄的慢性胰腺炎患者的支架置入是可接受的。